tldrdailynews.com logo

Novo Nordisk Shares Drop Amid Leadership Change and Profit Warnings

1 min read
Source: Investor's Business Daily
Novo Nordisk Shares Drop Amid Leadership Change and Profit Warnings
Photo: Investor's Business Daily
TL;DR

Novo Nordisk's stock fell 22% after lowering its 2025 sales and profit growth forecasts and appointing Maziar Mike Doustdar as the new CEO, amid increased competition for its diabetes and obesity drugs.

Topics:top-newsbusiness#business#lowered-guidance#market-challenges#new-ceo#novo-nordisk#stock-decline
Share this article
  1. Novo Nordisk Falls On Lowered Guidance. Pharma Giant Names New CEO.  Investor's Business Daily
  2. Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance  CNBC
  3. Novo Nordisk Shares Plummet as Competition Weighs on Sales  The Wall Street Journal
  4. Novo Nordisk outgoing CEO blames compounded GLP-1s for decline in 2025 outlook  Yahoo Finance
  5. Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning  The New York Times

Want the full story? Read the original reporting

Read on Investor's Business Daily